Medication info
Alphapoligem 5/160 mg

Alphapoligem 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.935mg / 1 tabletValsartan›160mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Dark yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201901228 · Approved 2019.02.26 · Insurance code 670501390

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is needed in patients with mild or moderate renal impairment (creatinine clearance of 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years or older: Use caution when increasing the dose.
Child dose
This medicine is not recommended for pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or valsartan alone. It helps to effectively lower blood pressure and reduce the burden on the vessels and heart.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is needed in patients with mild or moderate renal impairment (creatinine clearance of 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years or older: Use caution when increasing the dose.

Child dose

This medicine is not recommended for pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or those with certain kidney and liver diseases should not take it, nor should pregnant or breastfeeding women. Patients with low sodium or fluid levels in the body may experience hypotension, so their condition should be checked before taking this medication, and blood pressure should be carefully monitored during use. Patients with high potassium levels should frequently check their potassium levels when taking this medication along with drugs that can increase potassium. Patients with kidney diseases or who have received kidney transplants must closely monitor kidney function while taking this medication, and should discontinue use if symptoms of angioedema appear. Patients with heart failure or myocardial infarction should regularly evaluate their condition, including changes in kidney function, when taking this medication, and cautious use is required in severe heart failure patients. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other antihypertensive drugs or specific medications, so any other medications being taken should be disclosed to medical personnel. Overdose may result in symptoms such as hypotension and increased heart rate, so care should be taken not to exceed the recommended dose. This medication is not recommended for children under 18 years of age, as its safety and efficacy have not been sufficiently established. In the elderly, it can be taken at the standard adult dosage, but should follow the guidance of medical personnel based on individual physical condition. If abnormal symptoms or side effects occur during use, consult medical personnel immediately, and it is important to ensure safety through regular blood pressure and blood tests.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, rash, joint swelling, low back pain, arthritis, muscle spasms, lethargy, urinary frequency, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, including serum sickness hypersensitivity, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin discoloration, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitation, sensory impairment, Stevens-Johnson syndrome, dizziness, fatigue, sudden drop in blood pressure, hypotension, pulmonary edema, decreased urination, progressive hyperazotemia, acute renal failure, death, angina pectoris, acute myocardial infarction, increased blood urea, increased serum creatinine, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea, non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture, and it is best to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the medication’s effectiveness.

Appearance and packaging

Appearance

Dark yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.